Modulo Bio
2 known investors
Modulo is a drug discovery company developing therapies that reprogram microglia — the brain's immune cells — to treat neurological conditions. It combines stem cell engineering, neurobiology, multiomics, CRISPR, single-cell techniques, and machine learning to model the neuroimmune system and identify neuroprotective microglial behaviors.
AI & Machine LearningBiotechDeep Tech
Investors · 2
Frequently asked questions
- What does Modulo Bio do?
- Modulo is a drug discovery company developing therapies that reprogram microglia — the brain's immune cells — to treat neurological conditions. It combines stem cell engineering, neurobiology, multiomics, CRISPR, single-cell techniques, and machine learning to model the neuroimmune system and identify neuroprotective microglial behaviors.
- Who are Modulo Bio's investors?
- Modulo Bio's investors include Cantos Ventures, Spacecadet Ventures.